These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17687137)

  • 41. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
    Biot Sdel R; Franco JP; Lima RB; Pereira HN; Marques LP; Martins CJ
    An Bras Dermatol; 2014; 89(6):980-4. PubMed ID: 25387507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An antibody treats almost all refractory autoimmune diseases: fact and beyond.
    Lin LY; Hsu MH; Yang KD
    J Formos Med Assoc; 2012 Apr; 111(4):181-2. PubMed ID: 22655322
    [No Abstract]   [Full Text] [Related]  

  • 43. Rituximab exerts a dual effect in pemphigus vulgaris.
    Eming R; Nagel A; Wolff-Franke S; Podstawa E; Debus D; Hertl M
    J Invest Dermatol; 2008 Dec; 128(12):2850-8. PubMed ID: 18563178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases].
    Kasperkiewicz M; Zillikens D
    Hautarzt; 2007 Feb; 58(2):115-6, 118-21. PubMed ID: 17237928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effectiveness and safety of rituximab in pemphigus vulgaris].
    Alonso Sánchez A; García Rodríguez S; López Avila A; Rabell Iñigo S
    Farm Hosp; 2010; 34(2):98-9. PubMed ID: 20304370
    [No Abstract]   [Full Text] [Related]  

  • 46. Generalized erythrodermic pemphigus foliaceus in a child and its successful response to rituximab treatment.
    Connelly EA; Aber C; Kleiner G; Nousari C; Charles C; Schachner LA
    Pediatr Dermatol; 2007; 24(2):172-6. PubMed ID: 17461818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blisters in disguise.
    Dowlatshahi EA; Diercks G; van Doorn M
    BMJ; 2018 Jan; 360():j5364. PubMed ID: 29301743
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities.
    Cho HH; Jin SP; Chung JH
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):186-91. PubMed ID: 23356542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-Term Remissions in Recalcitrant Pemphigus Vulgaris.
    Ahmed AR; Kaveri S; Spigelman Z
    N Engl J Med; 2015 Dec; 373(27):2693-4. PubMed ID: 26716930
    [No Abstract]   [Full Text] [Related]  

  • 50. Rituximab in dermatological diseases.
    Troiano M; Lotti T
    G Ital Dermatol Venereol; 2009 Aug; 144(4):495-9. PubMed ID: 19755955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
    Sundharam J
    Indian J Dermatol Venereol Leprol; 2006; 72(2):173-4. PubMed ID: 16707836
    [No Abstract]   [Full Text] [Related]  

  • 52. Current therapy of the pemphigus group.
    Kasperkiewicz M; Schmidt E; Zillikens D
    Clin Dermatol; 2012; 30(1):84-94. PubMed ID: 22137231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical observation of different doses of rituximab for the treatment of severe pemphigus: A single-center prospective cohort study.
    Zhang J; Huang X; Zhang Z; Zhao P; Chen W; Liang Y; Liu H; Zhong Z; Chen Y
    J Am Acad Dermatol; 2023 Feb; 88(2):500-502. PubMed ID: 35779637
    [No Abstract]   [Full Text] [Related]  

  • 54. Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases.
    Baum S; Gilboa S; Greenberger S; Pavlotsky F; Trau H; Barzilai A
    J Dermatolog Treat; 2013 Dec; 24(6):427-30. PubMed ID: 23521340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
    Prodanovic EM; Korman NJ
    J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment failure with rituximab in a patient with pemphigus vulgaris.
    Weger W; Aberer E
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):387-9. PubMed ID: 18269618
    [No Abstract]   [Full Text] [Related]  

  • 57. Current treatment of autoimmune blistering diseases.
    Kasperkiewicz M; Schmidt E
    Curr Drug Discov Technol; 2009 Dec; 6(4):270-80. PubMed ID: 20025595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acquired haemophilia treated successfully with rituximab in a patient with pemphigus vulgaris.
    Chiba T; Tsuji G; Mitoma H; Takahara M; Moroi Y; Miyamoto T; Furue M
    Haemophilia; 2013 Mar; 19(2):e98-9. PubMed ID: 23419110
    [No Abstract]   [Full Text] [Related]  

  • 59. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
    Tanaka Y
    Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature.
    Cianchini G; Corona R; Frezzolini A; Ruffelli M; Didona B; Puddu P
    Arch Dermatol; 2007 Aug; 143(8):1033-8. PubMed ID: 17709662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.